Xanthine oxidase-IN-20

Overview

Xanthine oxidase-IN-20 is a potent and orally active xanthine oxidase ( XO ) inhibitor with an IC 50 of 1.7 nM. Xanthine oxidase-IN-20 exhibits outstanding serum uric acid (SUA)-lowering efficacy in both mouse and rat acute hyperuricemia models. Xanthine oxidase-IN-20 shows favorable safety profile. Xanthine oxidase-IN-20 can be used for hyperuricemia and gout research.

Application

Products | Products > Disease Areas > Gout | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Purine Metabolism | Products > Disease Areas > Arthritis | Products > Disease Areas > Hyperuricemia | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Xanthine Oxidase

Product Information

• Catalog No.: HY-180186
• CAS No.: 3069916-11-3
• Molecular Formula: C21H22N6O6
• Molecular Weight: 454.44
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source